Redeye: Alzinova - Unique vaccine angle on Alzheimer’s
Redeye initiates coverage of Alzinova, an early-stage biotech that develops a disease-modifying vaccine against Alzheimer’s disease.
Read more and download the Research Update: http://bit.ly/2RYtSjq
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/